TY - JOUR
T1 - Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered allo antigen
AU - Sayegh, Mohamed H.
AU - Jenny Zhang, Z.
AU - Hancock, Wayne W.
AU - Kwok, Cheng A.
AU - Carpenter, Charles B.
AU - Weiner, Howard L.
PY - 1992/1
Y1 - 1992/1
N2 - The effects of oral administration of major histocompatibility antigens on the alloimmune response have not been investigated. Lymphocytes from inbred LEW (RT1U) rats that were pre-fed allogeneic WF (RT11) splenocytes exhibited significant antigen specific reduction of the mixed lymphocyte response in vitro and delayed-type hypersensitivity response in vivo, when compared with unfed controls. In an accelerated allograft rejection model, LEW rats were presensitized with BN (RTln) skin allografts 7 days before challenging them with (LEWxBN)F! or BN vascularized cardiac allografts. While sensitized control animals hypera-cutely reject their cardiac allografts within 2 days, animals prefed with BN splenocytes maintained cardiac allograft survival to 7 days, a time similar to that observed in unsensitized control recipients. This phenomenon was antigen-specific, as third-party WF grafts were rejected within 2 days. Immunohistologic examination of cardiac allografts harvested on day 2 from the fed animals had markedly reduced deposition of IgG, IgM, C3, and fibrin. In addition, there were significantly fewer cellular infiltrates of total white blood cells, neutrophils, macrophages, T cells, IL-2 receptor-positive T cells, and mononuclear cells with positive staining for the activation cytokines IL-2 and IFN-g. On day 6 post-transplant, the grafts from fed animals showed immunohistologic changes typical of acute cellular rejection usually seen in unsensitized rejecting controls. Feeding allogeneic splenocytes prevents sensitization by skin grafts and transforms accelerated rejection of vascularized cardiac allografts to an acute form typical of unsensitized recipients. Oral administration of alloantigen provides a novel approach to down-regulate the specific systemic alloimmune response against histocompatibility antigens. Copyright
AB - The effects of oral administration of major histocompatibility antigens on the alloimmune response have not been investigated. Lymphocytes from inbred LEW (RT1U) rats that were pre-fed allogeneic WF (RT11) splenocytes exhibited significant antigen specific reduction of the mixed lymphocyte response in vitro and delayed-type hypersensitivity response in vivo, when compared with unfed controls. In an accelerated allograft rejection model, LEW rats were presensitized with BN (RTln) skin allografts 7 days before challenging them with (LEWxBN)F! or BN vascularized cardiac allografts. While sensitized control animals hypera-cutely reject their cardiac allografts within 2 days, animals prefed with BN splenocytes maintained cardiac allograft survival to 7 days, a time similar to that observed in unsensitized control recipients. This phenomenon was antigen-specific, as third-party WF grafts were rejected within 2 days. Immunohistologic examination of cardiac allografts harvested on day 2 from the fed animals had markedly reduced deposition of IgG, IgM, C3, and fibrin. In addition, there were significantly fewer cellular infiltrates of total white blood cells, neutrophils, macrophages, T cells, IL-2 receptor-positive T cells, and mononuclear cells with positive staining for the activation cytokines IL-2 and IFN-g. On day 6 post-transplant, the grafts from fed animals showed immunohistologic changes typical of acute cellular rejection usually seen in unsensitized rejecting controls. Feeding allogeneic splenocytes prevents sensitization by skin grafts and transforms accelerated rejection of vascularized cardiac allografts to an acute form typical of unsensitized recipients. Oral administration of alloantigen provides a novel approach to down-regulate the specific systemic alloimmune response against histocompatibility antigens. Copyright
UR - http://www.scopus.com/inward/record.url?scp=0026595059&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026595059&partnerID=8YFLogxK
U2 - 10.1097/00007890-199201000-00033
DO - 10.1097/00007890-199201000-00033
M3 - Article
C2 - 1733066
AN - SCOPUS:0026595059
SN - 0041-1337
VL - 53
SP - 163
EP - 166
JO - Transplantation
JF - Transplantation
IS - 1
ER -